PDE4B Inhibitor Synthesis With Staged Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for large-scale manufacturing of the PDE4B-inhibitor of formula XX, as described in U.S. Pat. No. 8,609,670, are inefficient, produce impurities, and are not cost-effective, leading to low yields and high waste generation.
Innovation Solution
The method involves a series of improved synthesis steps, including a Suzuki-reaction for Intermediate VIII, reduced catalyst usage, additional crystallization steps to remove triethylammonium salts, a stereoselective oxidation step with a preincubation process, and optimized recrystallization procedures to enhance purity and reduce titanium and enantiomeric impurities, resulting in higher yields and reduced environmental impact.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the existing manufacturing method (U.S. Pat. No. 8,609,670) is used, then the PDE4B-inhibitor can be synthesized, but the yield is low and impurities are produced
Solution Approach 1:
The synthesis process is divided into multiple discrete steps with specific intermediates (Intermediates I-XIX), each optimized for purity. The process segments include: chlorination of thieno-pyrimidine, Suzuki-coupling with piperidine, hydrogenation, oxidation with chiral catalyst, and crystallization steps. Each segment is designed to minimize impurity formation at that specific stage.
Solution Approach 2:
The patent employs preliminary crystallization steps (Steps d and e) before the final product formation to remove impurities early in the process. Intermediate VIII undergoes crystallization to remove triethylammonium salts, and Intermediate XVII undergoes crystallization to remove titanium catalyst residues, preventing these impurities from carrying through to the final product.
2Productivity
If the existing manufacturing method is used, then the PDE4B-inhibitor can be synthesized, but waste generation is high
Solution Approach 1:
The patent recovers and reuses solvents and reagents at each step. For example, the crystallization steps use solvent systems that are recovered from the mother liquor and reused. The chiral catalyst system (Ti(OiPr)4 with S-(−)-binaphthol) is designed for high efficiency with minimal waste, and the catalyst can be recovered from the reaction mixture.
3Manufacturing precision
If additional crystallization steps are added to remove impurities, then purity increases, but processing time increases
Solution Approach 1:
Crystallization steps are performed at intermediate stages (Step d for Intermediate VIII, Step e for Intermediate XVII) rather than only at the end. This preliminary purification removes impurities early when they are easiest to eliminate, reducing the need for extended final purification steps and overall processing time.
Solution Approach 2:
The crystallization steps use optimized temperature and solvent parameter changes to achieve rapid purification. For example, Intermediate VIII crystallization uses temperature control from room temperature to 0-10°C, and Intermediate XVII crystallization uses temperature control from 60-70°C to 0-10°C, achieving efficient separation in controlled time frames.
4Manufacturing precision
If chiral catalyst is used for stereoselective oxidation, then enantiomeric purity increases, but catalyst cost increases
Solution Approach 1:
The chiral catalyst system (Ti(OiPr)4 with S-(−)-binaphthol) is designed for high efficiency with minimal waste, and the catalyst can be recovered from the reaction mixture. The patent optimizes the catalyst loading and recovery process to make the expensive chiral catalyst economically viable at scale.
Solution Approach 2:
The oxidation step uses optimized parameters including temperature (20-40°C), catalyst loading, and substrate-to-catalyst ratio to maximize enantiomeric purity while minimizing catalyst consumption. The preincubation step (Step c) ensures optimal catalyst activation before substrate addition, improving efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The improved method achieves higher purity and yield of intermediates, reduces catalyst and solvent usage, and shortens processing times, making it more economical and environmentally friendly for large-scale production.
Implementation Method 1
a palladium-mediated cross-coupling, generating the coupling product VI
Implementation Method 2
The latter compound VI is then hydrogenated to the non-isolated Intermediate VII
Implementation Method 3
treated with hydrochloric acid to form the hydrochloride VIII
Implementation Method 4
a stereoselective oxidation step with a preincubation process
Implementation Method 5
additional crystallization steps to remove triethylammonium salts
Implementation Method 6
optimized recrystallization procedures to enhance purity and reduce titanium and enantiomeric impurities
Data Source
AI summary
The invention is directed to an improved method of manufacturing the PDE4B-inhibitor of formula XX